Genesis Biotechnology Group has completed the acquisition of PharmOptima, which will enable the former to provide its customers a single point-of-contact for the development and co-ordination of their unique pre-clinical drug development programme.
The acquirer company is a US-based biotechnology firm, whereas the target company is a contract research organisation also based in the US.
Betta Pharmaceuticals has announced its intention to acquire 77.4% stake in AnewPharma.
Both companies involved in the transaction are pharmaceutical organisations based in China.
The purchase consideration for the acquisition is expected to be ¥371.6m ($54.08m).
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
![](/wp-content/themes/goodlife-wp-B2B/assets/images/company-profile-unit.png)
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData